Physician profile
Karin Johnson
NPI 1699362293
$328.73
in general payments reported to CMS, 2019-2025
11 companies · $82.43 in 2025
The $82.43 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $81.35 · 2024: $165 · 2025: $82.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $83.61 | 2023-2025 | Valtoco |
| Pfizer INC. | $43.17 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $40.95 | 2023 | Jornay Pm |
| Noven Therapeutics, LLC | $24.79 | 2024 | Xelstrym |
| Astellas Pharma US INC | $24.70 | 2024 | Veozah |
| Spr Therapeutics, INC | $23.36 | 2024 | Sprint Pns System |
| Merck Sharp & Dohme LLC | $21.49 | 2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Cipher Pharmaceuticals US LLC | $20.19 | 2025 | Natroba, Spinosad |
| Biomarin Pharmaceutical INC. | $17.88 | 2025 | Voxzogo 1.2mg |
| Cranial Technologies, INC | $15.30 | 2024 | Doc Band |
| Medtronic, INC. | $13.29 | 2024 | Kyphon Express II Kyphopak Tray |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karin Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.